<DOC>
	<DOCNO>NCT02398032</DOCNO>
	<brief_summary>Study objective : To assess nocturnal change mechanosensitivity chemosensitivity hypertensive sleep apnea-hypopnea syndrome ( SAHS ) patient SAHS patient isolate nocturnal hypertension . To value continuous positive airway pressure ( CPAP ) effect parameter . Design : Controlled cross-over longitudinal study . Settings : Madrid metropolitan area . Patients : Day-night sustained hypertensive isolate nocturnal hypertensive patient SAHS without previous treatment . At least 30 patient need . Interventions : Patients allocate treatment arm ( CPAP vs. sham CPAP ) three month . Explorations perform immediately sleep 0- , 3- , 6-months trial . Measurements : 24-h urinary catecholamine , local vascular factor , angiotensin aldosterone level . Diaphragmatic tension-time index , metabolic rate , hypoxic withdrawal test , ventilatory inspiratory neural drive response progressive isocapnic hypoxia .</brief_summary>
	<brief_title>CPAP SAHS Patients With Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Apnea</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<criteria>Recent diagnosis sleep apneahypopnea syndrome apneahypopnea index ( AHI ) &gt; 10 h1 No previous treatment SAHS hypertension Diagnosis 24h ambulatory monitoring blood pressure ( AMBP ) isolate nocturnal hypertension ( nighttime blood pressure ≥120 mm Hg systolic 70 mm Hg diastolic daytime blood pressure &lt; 135/85 mm Hg ) daynight sustain hypertension ( nighttime blood pressure ≥120 mm Hg 70 mm Hg diastolic daytime blood pressure ≥135 mm Hg systolic ) . Severe hypertension ( &gt; 180/120 mmHg ) . Previous diagnosis secondary hypertension . Myocardial infarction stroke last three month . Severe diurnal sleepiness ( Epworth score &gt; 15 ) Previous diagnosis chronic obstructive pulmonary disease , asthma , bronchiectasis , lung cancer , restrictive lung disease , chest wall disease thoracic surgery . Previous diagnosis clinical evidence heart disease , neuromuscular disease thyroid dysfunction . Morbid obesity ( BMI &gt; 40 Kg/m2 ) Respiratory infection last two month . Treatment theophylline systemic corticosteroid last two year . Excessive alcohol intake ( &gt; 40 g/day ) Absence social familiar support .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>sleep apnea</keyword>
	<keyword>hypertension</keyword>
	<keyword>mechanosensitivity</keyword>
	<keyword>chemosensitivity</keyword>
	<keyword>adhesion factor</keyword>
</DOC>